NCT04351594View on ClinicalTrials.gov

Biofreeze and the Effect on Knee Osteoarthritis

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

November 1, 2020

Primary Completion Date

January 1, 2024

Study Completion Date

January 1, 2024

Conditions
Knee Osteoarthritis
Interventions
DRUG

Biofreeze 4 % Topical Gel

Biofreeze gel with active manufactured ingredient (Menthol 4%)

OTHER

Biofreeze placebo gel

Biofreeze gel with no active manufactured to have the same look, feel and odour as Biofreeze topical gel.

Trial Locations (1)

A1B3V6

Memorial University, Faculty of Medicine Department of Surgery, St. John's

All Listed Sponsors
lead

Memorial University of Newfoundland

OTHER

NCT04351594 - Biofreeze and the Effect on Knee Osteoarthritis | Biotech Hunter | Biotech Hunter